Cooke & Bieler LP Charles River Laboratories International, Inc. Transaction History
Cooke & Bieler LP
- $9.23 Billion
- Q4 2024
A detailed history of Cooke & Bieler LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cooke & Bieler LP holds 426,767 shares of CRL stock, worth $66.1 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
426,767
Previous 300,395
42.07%
Holding current value
$66.1 Million
Previous $59.2 Million
33.13%
% of portfolio
0.85%
Previous 0.6%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
695Shares Held
51.4MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$954 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$788 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$631 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$330 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$300 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.88B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...